Cadila Healthcare to sell 1.25 crore shares of Bayer Zydus Pharma

27 Apr 2018 Evaluate

Cadila Healthcare is selling 1,25,00,001 equity shares in Bayer Zydus Pharma at a value determined in terms of JVA to Bayer by executing a Share Purchase Agreement (SPA) amongst the company, Bayer and the Joint Venture Company (JVC) - Bayer Zydus Pharma.

Earlier, the company had entered into Joint Venture Agreement (JVA) with Bayer (South East Asia) (Bayer) on January 28, 2011. Both Bayer and the company hold 2.50 crore equity shares of Rs 10 each fully paid-up of Bayer Zydus Pharma.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×